BCBP
BCB Bancorp, Inc.
There isn't enough reported data to score BCBP yet.
JPM
JPMorgan Chase & Co.
JPM's fundamentals are strong, but it looks expensive: trading at 14x earnings, above its usual 12x. Analysts expect earnings growth.
BCBP Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| N/A | |
| N/A |
BCBP's revenue is currently stable, but its profitability is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like BCBP.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
BCBP PE Valuation
BCBP has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 19x next year's earnings.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
BCBP Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect BCBP to return to profit, with revenue growing. However, they disagree widely on these estimates.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
BCBP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.47 | — |
| Q3 2026 | -$8.24 | -13833% |
| Q2 2026 | -$1.10 | -650% |
| Q1 2026 | -$0.07 | -144% |
| Q4 2025 | -$0.84 | -185% |
| Q3 2025 | $0.06 | -95% |
| Q2 2025 | $0.20 | -83% |
| Q1 2025 | $0.16 | -90% |
| Q4 2024 | $0.99 | -42% |
BCBP has swung to a loss: it lost $8.24 per share over the past year, after a profit the year before.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over BCBP on earnings quality, reporting a profit while its opponent remains loss making.
BCBP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $27.8M | +5% |
| Q2 2026 | $22.9M | -9.1% |
| Q1 2026 | $24.9M | +4.8% |
| Q4 2025 | $26.2M | +13% |
| Q3 2025 | $26.5M | +1.1% |
| Q2 2025 | $25.2M | +23% |
| Q1 2025 | $23.8M | -5.8% |
| Q4 2024 | $23.1M | -15% |
BCBP's revenue has held roughly level: $28M last quarter, up 5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -392% | -414 points |
| Q2 2026 | -80% | -100 points |
| Q1 2026 | 26% | +76 points |
| Q4 2025 | -67% | -87 points |
| Q3 2025 | 22% | -14 points |
| Q2 2025 | 20% | +0.4 points |
| Q1 2025 | -49% | -82 points |
| Q4 2024 | 20% | -12 points |
BCBP's operating margin was −392% last quarter, down 414 points from the same quarter a year ago, near the bottom of its range since 2019.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over BCBP on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over BCBP on profitability, with a higher operating margin.
BCBP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.7M | -44% |
| Q2 2026 | $9.3M | -8.2% |
| Q1 2026 | $4.9M | +4% |
| Q4 2025 | $11.5M | +69% |
| Q3 2025 | $8.5M | -81% |
| Q2 2025 | $10.2M | +26% |
| Q1 2025 | $4.7M | -42% |
| Q4 2024 | $6.8M | +1339% |
BCBP has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
BCBP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +11% | +1.8M shares |
| 1 year | +11% | +1.9M shares |
| 3 years | +14% | +2.3M shares |
| 5 years | +11% | +1.9M shares |
| Available history | +17% | +2.7M shares |
BCBP has 19M diluted shares, up 11% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | $1.3M |
| Q1 2023 | $2.6M |
| Q4 2022 | $1.4M |
| Q3 2022 | $1.2M |
| Q2 2022 | $756,000 |
| Q1 2022 | $8,000 |
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over BCBP on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
BCBP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 19.3x | High |
| Q3 2025 | 5.7x | High |
| Q2 2025 | 3.5x | Elevated |
| Q1 2025 | 3.9x | Elevated |
| Q4 2024 | 17.3x | High |
| Q3 2024 | 1.7x | Healthy |
| Q2 2024 | 0.8x | Very low |
| Q1 2024 | 0.6x | Very low |
BCBP's net debt is about 19 years of its operating earnings (EBITDA), up from 17 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BCBP.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
BCBP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.8 | Neutral |
| Stochastic | 60.5 | Neutral |
BCBP's weekly RSI is 52 (neutral) and its Stochastic is 60 (neutral).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
BCBP PE vs Financial Services Sector
| Metric | BCBP | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
BCBP has no meaningful PE right now: it lost money over the past year.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
BCBP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $8.68 | 5.6% above |
| 20 week MA | $9.09 | 0.9% above |
| 50 week MA | $9.06 | 1.2% above |
| 100 week MA | $9.09 | 0.9% above |
| 200 week MA | $10.6 | 13% below |
BCBP has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 13% below its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
BCBP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $13.9 | $10.8 | -22% |
| 2021 | $10.8 | $15.6 | +45% |
| 2022 | $15.6 | $18.0 | +16% |
| 2023 | $18.0 | $12.9 | -29% |
| 2024 | $12.9 | $11.7 | -9.3% |
| 2025 | $11.7 | $8.27 | -29% |
| 2026 YTD | $8.27 | $9.17 | +11% |
BCBP has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.